Author

F. Fazekas

Primary ORCID profile (0000-0003-3832-4660 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

F. FazekasiD1 paper · University of Maryland, College Park

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. P. Rapoport· 1 shared A. Pathni· 1 shared A. Upadhyaya· 1 shared A. Wang· 1 shared D. Atanackovic· 1 shared D. Lum· 1 shared D. Yamoah· 1 shared E. Gebru· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. P. Rapoport

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Preventing trogocytosis by cathepsin B inhibition augments CAR T cell function

K. A. Dietze, K. Nguyen, A. Pathni, F. Fazekas, W. Sun, E. Rosati, J. M. Baker, M. Galeana Figueroa, E. Gebru, D. Yamoah, R. Mulatu, A. Wang, A. P. Rapoport, D. Lum, X. Fan, , T. Luetkens

This study shows that inhibiting cathepsin B prevents CAR T cell fratricide and exhaustion by blocking trogocytosis, improving CAR T cell persistence and anti-tumor activity.

bioRxiv · Jun 11, 2024Bioengineering